{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 1, First-in-human, Dose Escalation and Expansion, Multicenter Study of XMT-2056 in Participants with Advanced\/Recurrent Solid Tumors that Express HER2","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1-first-in-human-dose-escalation-and-expansion-multicenter-study-of-xmt-2056-in-participants-with-advanced-recurrent-solid-tumors-that-express-her2\/#breadcrumbitem"}]}